112 related articles for article (PubMed ID: 12471612)
1. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice.
Anisimov VN; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Manton KG; Semenchenko AV; Yashin AI
Int J Cancer; 2003 Jan; 103(3):300-5. PubMed ID: 12471612
[TBL] [Abstract][Full Text] [Related]
2. The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression.
Baturin DA; Alimova IN; Anisimov VN; Popovich IG; Zabezhinski MA; Provinciali M; Mancini R; Franceschi C
Neuro Endocrinol Lett; 2001 Dec; 22(6):441-7. PubMed ID: 11781542
[TBL] [Abstract][Full Text] [Related]
3. [Effect of antidiabetic drug diabenol on parameters of biological age, life span and tumor development in NMRI and HER-2/neu mice].
Popovich IG; Zabezhinskiĭ MA; Egormin PA; Anikin IV; Tyndyk ML; Semenchenko AV; Spasov AA; Anisimov VN
Adv Gerontol; 2004; 15():80-90. PubMed ID: 15754958
[TBL] [Abstract][Full Text] [Related]
4. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Khavinson VK; Provinciali M; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Imyanitov EN; Mancini R; Franceschi C
Int J Cancer; 2002 Sep; 101(1):7-10. PubMed ID: 12209581
[TBL] [Abstract][Full Text] [Related]
6. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.
Anisimov VN; Egormin PA; Piskunova TS; Popovich IG; Tyndyk ML; Yurova MN; Zabezhinski MA; Anikin IV; Karkach AS; Romanyukha AA
Cell Cycle; 2010 Jan; 9(1):188-97. PubMed ID: 20016287
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
8. Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Egormin PA; Bershtein LM; Zabezhinskii MA; Piskunova TS; Popovich IG; Semenchenko AV
Bull Exp Biol Med; 2005 Jun; 139(6):721-3. PubMed ID: 16224592
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM
Cancer Res; 2000 Jul; 60(13):3569-76. PubMed ID: 10910070
[TBL] [Abstract][Full Text] [Related]
10. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
11. Light-at-night-induced circadian disruption, cancer and aging.
Anisimov VN; Vinogradova IA; Panchenko AV; Popovich IG; Zabezhinski MA
Curr Aging Sci; 2012 Dec; 5(3):170-7. PubMed ID: 23237593
[TBL] [Abstract][Full Text] [Related]
12. Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Re F; Donnini A; Orlando F; Bartozzi B; Di Stasio G; Smorlesi A
Int J Cancer; 2005 May; 115(1):36-45. PubMed ID: 15688416
[TBL] [Abstract][Full Text] [Related]
13. Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA.
Sfondrini L; Besusso D; Rumio C; Rodolfo M; Ménard S; Balsari A
FASEB J; 2002 Nov; 16(13):1749-54. PubMed ID: 12409317
[TBL] [Abstract][Full Text] [Related]
14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
15. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL
Am J Pathol; 2005 Apr; 166(4):1205-16. PubMed ID: 15793299
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
[TBL] [Abstract][Full Text] [Related]
18. Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene.
Rao GN; Ney E; Herbert RA
Breast Cancer Res Treat; 2000 Dec; 64(3):287-96. PubMed ID: 11200779
[TBL] [Abstract][Full Text] [Related]
19. Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice.
Anisimov VN; Popovich IG; Alimova IN; Zabezhinski MA; Semenchenko AV; Yashin AI
Cancer Lett; 2003 Apr; 193(1):49-55. PubMed ID: 12691823
[TBL] [Abstract][Full Text] [Related]
20. Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span.
Provinciali M; Barucca A; Orlando F; Pierpaoli E
Sci Rep; 2017 Jun; 7(1):3078. PubMed ID: 28596550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
